Kardioselektivnyy beta-adrenoblokator bisoprolol v lechenii arterial'noy gipertenzii


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article is devoted to one of the main groups of drugs used in cardiology, - β-blockers (BB), in particular bisoprolol. Indications and contraindications for the use of BB, the principles of transition from monotherapy to combined therapy of arterial hypertension (AH) are presented. Particular attention is paid to the drug Bisogamma ®, a cardioselective BB without intrinsic sympathomimetic activity, which acts selectively on β-adrenergic receptors, and its antihypertensive effect is based on the reduction of cardiac output, inhibition of renin secretion by the kidneys. A multicomponent antihypertensive effect of Bisogamma® against the background of metabolic neutrality allows to recommend this cardioselective BB for the treatment of hypertensive patients with with obesity, disorders of blood lipid and glycemic profiles, and with chronic obstructive pulmonary disease.

Full Text

Restricted Access

About the authors

S. S Davydova

References

  1. Национальные рекомендации ВНОК и ОСССН по диагностике и лечению ХСН (второй пересмотр). Сердечная недостаточность. 2006;8:2.
  2. Глезер М.Г., Глезер Г.А. Справочник по фармакотерапии сердечно-сосудистых заболеваний. М., 1996; 564.
  3. Сидоренко Б.А., Преображенский Д.В. Фармакотерапия гипертонической болезни. РМЖ. 1998; 6: 19: 1228-37.
  4. Марцевич С.Ю., Толпыгина С.Н. Бета адреноблокаторы. В книге "Кардиология. Национальное руководство". Под ред. Ю.Н. Беленкова и Р.Г. Оганова. М., 2007; 377-395.
  5. Prichard B.N.C., Gillam P.M.S. Use of propranolol (Inderal) in treatment of hypertension. Br. Med. J. 1964; II: 725-27.
  6. Чазова И.Е., Мычка В.Б. Метаболический синдром. MTDIA MEDICA, 2004; 400.
  7. Benetos A., Adamopoulos C., Argyriadis P. et al. Clinical results with bisoprolol 2.5 mg/ hydrochlorothiazide 6.25 mg combination in systolic hypertension in the elderly. J Hypertens. 2002; 20(Suppl. 1):S21-25.
  8. Sorof J.M., Cargo P., Graepel J. et al. Betablocker/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial. Pediatr Nephrol. 2002;17:5:345-350.
  9. Шилов А.М. Бета-блокатор второго поколения в практике лечения артериальной гипертонии. Фарматека. 2008; 8.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2012 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies